A detailed history of Parkman Healthcare Partners LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 1,854,763 shares of APLT stock, worth $7.94 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
1,854,763
Previous 1,019,156 81.99%
Holding current value
$7.94 Million
Previous $3.41 Million 269.42%
% of portfolio
1.71%
Previous 0.49%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $1.88 Million - $6.18 Million
835,607 Added 81.99%
1,854,763 $12.6 Million
Q4 2023

Feb 14, 2024

SELL
$1.84 - $3.35 $1.34 Million - $2.45 Million
-730,844 Reduced 41.76%
1,019,156 $3.41 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $2.21 Million - $4.85 Million
1,750,000 New
1,750,000 $4.36 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $206M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.